Quality of life and survival after transmyocardial laser revascularization with the holmium:YAG laser

Annals of Thoracic Surgery

Volumn 75, Issue 6, 2003, Pages 1842-1848

  Guleserian, Kristine J ^a   Maniar, Hersh S ^a   Camillo, Cindy J ^a   Bailey, Marci S ^a   Damiano Jr , Ralph J ^a   Moon, Marc R ^a,b   Sundt, Thoralf ^c   Pennington, Glenn ^c   Jones, James ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Cardiothoracic Surgery   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HOLMIUM LASER; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVASCULARIZATION; STATISTICAL SIGNIFICANCE; SURVIVAL; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; LASER SURGERY; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; RISK FACTORS; SURVIVAL ANALYSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0038651098     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)00178-4     Document Type: Article

References (21)

1. Schofield PM, Sharples LD, Caine N, et al. Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet 1999;353:519-24.
2. Allen KB, Dowling RD, Fudge TL, et al. Comparison of transmyocardial laser revascularization with medical therapy in patients with refractory angina. N Engl J Med 1999;341:1029-36.
3. Burkoff D, Schmidt S, Schulman P, et al. Transmyocardial laser revascularization compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. Atlantic Investigators Angina Treatments - Lasers and Normal Therapies in Comparison. Lancet 1999;354:885-90.
4. Frazier OH, March RJ, Horvath KA. Transmyocardial laser revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. N Engl J Med 1999;341:1021-8.
5. Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle angina questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol 1995;25:333-41.
6. Spertus JA, Winder JA, Dewhurst TA, Deyo RA, Fihn SD. Monitoring the quality of life in patients with coronary artery disease. Am J Cardiol 1994;74:1240-4.
7. Sundt TM, Moon MR. Primary transmyocardial laser revascularization for end-stage coronary artery disease. Op Tech Thorac Cardiovasc Surg 2001;6:118-31.
8. Allen KB, Dowling RD, DelRossi AJ, et al. Transmyocardial laser revascularization combined with coronary artery bypass grafting: a multicenter, blinded, prospective, randomized, controlled trial. J Thorac Cardiovasc Surg 2000;119:540-9.
9. Moon MR, Sundt TM, Pasque MK, Barner HB, Gay WA, Damiano RJ. Influence of internal mammary artery bypass grafting and completeness of revascularization on long-term outcome in octogenarians. Ann Thorac Surg 2001;72:2003-7.
10. Horvath KA, Mannting F, Cummings N, Shernan SK, Cohn LH. Transmyocardial laser revascularization. Operative techniques and clinical results at two years. J Thorac Cardiovasc Surg 1996;111:1047-53.
11. Milano A, Pratali S, Tartarini G, Mariotti R, DeCarlo M, Paterni G, et al. Early results of transmyocardial revascularization with a holmium laser. Ann Thorac Surg 1998;65:700-4.
12. Hattler BG, Griffith BP, Zenati MA, et al. Transmyocardial laser revascularisation in the patient with unmanageable unstable angina. Ann Thorac Surg 1999;68:1203-9.
13. Burkhoff D, Wesley MN, Resar JR, Lansing AM. Factors correlating with risk of mortality after transmyocardial revascularization. J Am Coll Cardiol 1999;341:55-61.
14. Tjomsland O, Aaberge L, Almdahl SM, et al. Perioperative cardiac function and predictors for adverse events after transmyocardial laser treatment. Ann Thorac Surg 2000;69:1098-103.
15. Krabatsch T, Petzina R, Hausmann H, Koster A, Hetzer R. Factors influencing results and outcome after transmyocardial laser revascularization. Ann Thorac Surg 2002;73:1888-92.
16. Hughes GC, Landolfo KP, Lowe JE, Coleman RB, Donovan CL. Perioperative morbidity and mortality after transmyocardial laser revascularization. Incidence and risk factors for adverse events. J Am Coll Cardiol 1999;33:1021-6.
17. 2 laser. Circulation 2001;104(Suppl I):I-81-4.
18. 2 laser revascularization improves symptoms, function, and quality of life: 12-month results from a randomized controlled trial. Am J Med 2001;111:341-8.
19. De Carlo M, Milano AD, Pratali S, Levantino M, Mariotti R, Bortolotti U. Symptomatic improvement after transmyocardial laser revascularization. How long does it last? Ann Thorac Surg 2000;70:1130-3.
20. Schneider J, Diegeler A, Krakor R, Walther T, Kluge R, Mohr FW. Transmyocardial laser revascularization with the holmium: YAG laser. Loss of symptomatic improvement after 2 years. Eur J Cardiothorac Surg 2001;19:164-9.
21. Lansing AM. Transmyocardial revascularization. Mechanism of action with carbon dioxide and holmium-yttrium-aluminum-garnet lasers. J Thorac Cardiovasc Surg 1998;115:1392.